stockrowANI Pharmaceuticals, Inc. (ANIP) vs Eton Pharmaceuticals, Inc. (ETON)
- ANI Pharmaceuticals, Inc. ANIP 69.00 −0.89%
- Eton Pharmaceuticals, Inc. ETON 55.17 +17.01%
ANI Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. is the larger, with a market value of $1.6B against $1.4B — 1.2× the size. ANI Pharmaceuticals, Inc. trades at the lower P/E: 13.3× against 26.8×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 100.6% against 25.9%. Eton Pharmaceuticals, Inc. has the higher net margin (35.4% vs 11.2%) and the higher return on invested capital (46.8% vs 46.4%). Across the 21 metrics below, ANI Pharmaceuticals, Inc. leads on 12 and Eton Pharmaceuticals, Inc. on 9.
Valuation
Profitability
| Metric | ANIP | ETON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 61.06% | 69.15% | 53.51% |
| Operating margin | 15.99% | 28.84% | 0.00% |
| Net margin | 11.22% | 35.35% | (2.45%) |
| Free cash flow margin | 19.72% | 14.17% | 0.00% |
| Return on equity | 20.45% | 90.62% | (0.80%) |
| Return on assets | 7.85% | 38.10% | (1.67%) |
| Return on invested capital | 46.43% | 46.77% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack